RESEARCHER MAKE BREAKTHROUGH IN DETECTING ALZHEIMER'S MUCH BEFORE ITS ONSET !
A
newly-developed brain scan has the amazing ability to spot the
debilitating Alzheimer’s disease in patients -15 years before any of the
symptoms begin to appear.
Researchers
at University College London are responsible for perfecting a type of
PET scan called amyloid PET. This type of scan allows them to use
radioactive tracers in the brain. In turn, this allows for certain
proteins, which are clear indicators of Alzheimer’s, to be spotted.
What’s more, the technique can also be deployed to spot other
debilitating diseases related to Alzheimer’s.
The researchers used the new
scanning method to find and measure amyloid protein plaques in the
brain, which in turn allowed them to chart the progression (or lack
thereof) in patients under observation.
So what makes this newly-developed scan different from a regular PET scan? There’s actually a single, principle difference – the newly-developed scan uses a different imaging agent than a regular PET scan. It binds to deposits of naturally occurring beta-amyloid proteins in the brain, which makes them easier to spot.
You may be asking what difference the early identification of a neurodegenerative disease that has no cure makes for patients, and the answer is that spotting Alzheimer’s 15 years before symptoms begin to emerge allows preventive lifestyle action to be taken. Furthermore, another benefit of early detection is that patients will be able to use new medications and therapies as and when they come out.
Researchers believe that the new
technology will allow them to develop new medications and therapies
that actually diminish the effects of Alzheimer’s significantly enough
for patients to maintain adequate cognitive function.
Plaques that build up within the brain, known as tau and amyloid, are believed to trigger Alzheimer’s when they are found in combination, however in a further development to the brain scan, a new drug called Aducanumab has been shown to significantly reduce the proliferation of amyloid plaques within the brain.
Both of the new developments have researchers very excited about the possibility that Alzheimer’s disease will be consigned to the history books in years to come.
this is only for your
information, kindly take the advice of your doctor for medicines,
exercises and so on.
So what makes this newly-developed scan different from a regular PET scan? There’s actually a single, principle difference – the newly-developed scan uses a different imaging agent than a regular PET scan. It binds to deposits of naturally occurring beta-amyloid proteins in the brain, which makes them easier to spot.
You may be asking what difference the early identification of a neurodegenerative disease that has no cure makes for patients, and the answer is that spotting Alzheimer’s 15 years before symptoms begin to emerge allows preventive lifestyle action to be taken. Furthermore, another benefit of early detection is that patients will be able to use new medications and therapies as and when they come out.
Plaques that build up within the brain, known as tau and amyloid, are believed to trigger Alzheimer’s when they are found in combination, however in a further development to the brain scan, a new drug called Aducanumab has been shown to significantly reduce the proliferation of amyloid plaques within the brain.
Both of the new developments have researchers very excited about the possibility that Alzheimer’s disease will be consigned to the history books in years to come.
this is only for your
information, kindly take the advice of your doctor for medicines,
exercises and so on.
https://gscrochetdesigns.
https://gseasyrecipes.
https://kneereplacement-
Labels: Alzheimer’s, amyloid plaques, beta-amyloid proteins, cognitive function, debilitating illness, neurodegenerative diseases, PET scan, radioactive tracers
posted by G S Iyer at 10:07 AM
0 Comments:
Post a Comment
<< Home